Core Insights - Health 160 International Limited has been included in the Hang Seng Composite Index, marking a significant milestone since its listing on the Hong Kong Stock Exchange in September 2025 [1][2] - The inclusion is expected to enhance the company's liquidity and valuation as it will attract investment from index funds [1][2] Group 1: Index Inclusion and Market Impact - The inclusion in the Hang Seng Composite Index will take effect after the market closes on March 6, 2026, and will officially start on March 9, 2026 [1] - Health 160's entry into multiple indices, including the Hang Seng Healthcare Index and the Hang Seng Stock Connect indices, is anticipated to broaden its investment appeal to institutional investors [1][2] Group 2: Access to Mainland Investors - Being part of the Hang Seng Composite Index is a crucial prerequisite for inclusion in the Stock Connect program, which allows mainland investors to directly invest in Health 160 [3] - This access to mainland capital is expected to provide a stable influx of funds, improving the company's shareholder structure and stock liquidity [3] Group 3: Business Model and Growth Potential - Health 160 operates a dual-driven business model combining "pharmaceutical health product sales" and "digital healthcare solutions," positioning it as a leader in China's digital healthcare sector [4] - The company has established a vast network, connecting over 44,800 healthcare institutions and 5.69 million registered users, creating a significant competitive barrier [4] Group 4: Financial Outlook and Analyst Ratings - Analysts have expressed optimism regarding Health 160's long-term value, with several brokerage firms initiating coverage and issuing "buy" ratings [5] - Target prices from analysts suggest substantial upside potential, with estimates indicating a nearly 70% increase from current stock prices [5]
健康160（02656.HK）获纳入恒生综合指数及系列主题指数，迈向港股通开启价值新篇章